VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, December 29, 2025
Stock Comparison
Edenred SE vs Merck & Co., Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Edenred SE
EDEN · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Merck & Co., Inc.
MRK · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Merck & Co., Inc.'s moat claims, evidence, and risks.
View MRK analysisComparison highlights
- Moat score gap: Merck & Co., Inc. leads (71 / 100 vs 67 / 100 for Edenred SE).
- Segment focus: Edenred SE has 3 segments (65.2% in Benefits & Engagement); Merck & Co., Inc. has 2 segments (89.5% in Pharmaceutical).
- Primary market structure: Oligopoly vs Competitive. Pricing power: Moderate vs Moderate.
- Moat breadth: Edenred SE has 7 moat types across 5 domains; Merck & Co., Inc. has 5 across 3.
Primary market context
Edenred SE
Benefits & Engagement
Employee benefits and engagement solutions (meal vouchers, gift/incentives, engagement platforms)
Global
Employers / HR departments
Issuer + payment network orchestrator (specific-purpose payments)
65.2%
Merck & Co., Inc.
Pharmaceutical
Branded prescription pharmaceuticals & human vaccines
Global
Wholesalers/retailers, managed care and government payers, hospitals/clinics
R&D-intensive innovator, manufacturer, and marketer
89.5%
Side-by-side metrics
Moat coverage
Shared moat types
Edenred SE strengths
Merck & Co., Inc. strengths
Segment mix
Edenred SE segments
Full profile >Benefits & Engagement
Oligopoly
Mobility
Oligopoly
Complementary Solutions
Competitive
Merck & Co., Inc. segments
Full profile >Pharmaceutical
Competitive
Animal Health
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.